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Mortality associated with passive smoking in Hong Kong
S M McGhee, S Y Ho, M Schooling, L M Ho, G N Thomas, A J Hedley, K H Mak, R Peto, T H Lam
Passive smoking can cause death from lung cancer and
coronary heart disease, but there is little evidence for
associations with other causes of death in never smok-
ers. A recent study showed increased all cause mortal-
ity with exposure to secondhand smoke at home but
did not examine associations with specific causes of
death and dose-response relations.1 We have published
estimates of the mortality attributable to active
smoking in Hong Kong2 and now present the related
findings on passive smoking at home.
Participants, methods, and results
Details of the sample selection and data collection have
been reported.2 Each person who reported a death in
1998 at four death registries was given a questionnaire
which asked about the lifestyle 10 years earlier of the
decedent and of a living person about the same age who
was well known to the informant. Passive smoking was
identified in the interview with the question, “Ten years
ago, in about 1988, excluding the decedent/control, how
many persons who lived with the decedent/control
smoked?” Decedents or controls who lived with one or
more smokers were classed as exposed. Cause of death
was obtained from the death certificate.
We selected never smoking decedents and controls
aged 60 years or over because there were few younger
controls. To avoid selection bias, we included only cases
and controls who had a living spouse at the time of
reporting. We used logistic regression to derive odds
ratios adjusted for age and education, and for sex when
men and women were combined.
We identified 4838 never smoking cases (55%
male) and 763 never smoking controls (55% male). All
controls were used in the analysis for each specific
cause of death.
We found significant dose dependent associations
between passive smoking and mortality from lung
cancer, chronic obstructive pulmonary disease, stroke,
ischaemic heart disease, and from all cancers, all respi-
ratory and circulatory diseases, and all causes (table).
The association between mortality and passive
smoking did not differ between males and females.
Deaths due to injury or poisoning were not associated
with passive smoking.
Comment
Dose dependent associations between passive smoking
and causes of death are consistent with previous
findings for lung cancer and coronary heart disease
and extend the evidence on stroke. Previous studies
have shown associations between passive smoking and
first acute strokes,3 4 and we have now shown a
dose-response relation with mortality from stroke. Pre-
vious studies focused on ischaemic strokes but Chinese
populations have a greater incidence of haemorrhagic
stroke than do white populations,5 implying that many
of the strokes in our study may have been
non-ischaemic. Passive smoking probably affects all
stroke subtypes, as does active smoking.
Our finding of a 34% increase in all cause mortality
is consistent with but higher than that (15%) in the New
Zealand cohort.1 Exposure to secondhand smoke at
home is higher in Hong Kong than in New Zealand
due to crowded living conditions. Before the 1990s,
awareness of the danger of passive smoking was lower
and smokers smoked freely at home.
We focused on passive smoking at home because
the proxy reporter could most reliably supply these
data, and we adjusted for education, which was also
What is known on this topic
There is strong evidence that passive smoking is
causally associated with death from lung cancer,
coronary heart disease, and all causes, and also
with acute stroke
What this study adds
The dose-response relation between passive
smoking and mortality from stroke and chronic
obstructive pulmonary disease, as well as from
lung cancer, ischaemic heart disease, and all
causes of death, strengthens the causal link This article was posted on bmj.com on 27 January 2005: http://bmj.com/
cgi/doi/10.1136/bmj.38342.706748.47
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reliably recorded2 and is a good proxy for social class in
Hong Kong. As data on cases and controls were
derived from the same proxy, reporting bias should be
minimal.2 If our results are not due to residual
confounding, they provide further evidence that the
dose-response associations between passive smoking
and stroke and all cause mortality are likely to be
causal.
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Q&A
Women’s experiences of breast and ovarian cancer
Question
Where can I read how other women responded when
they were diagnosed as having breast and ovarian
cancer?
T Scarlett Epstein, director and development economist,
PEGS, 5 Viceroy Lodge, Hove
Answer
ACOR (Association of Cancer On Line Resources) is
an excellent online group at www.acor.org. It is
primarily comprised of survivors and care givers, but
medical professionals also contribute. It lists over 100
disease sites, and I would recommend the Ovarian
Cancer Problems Discussion Group as there are
several women with dual primaries or genetically
predisposed because of BRCA1 or BRCA2.
Sandi Pniauskas, ovarian cancer survivor and advocate
Answer
I strongly recommend the DIPEx website which
(according to the home page) “was created by Dr Ann
McPherson CBE and Dr Andrew Herxheimer after
their own experiences of illness. Ann had been
diagnosed with breast cancer and although she knew
all the medical information, couldn’t find anyone else
to talk to about what it was really like to have the
disease.” It’s a fascinating collection of narratives.
There’s no section on ovarian cancer yet, but a large
section about breast cancer at www.dipex.org/Issues/
?ILLNESS = bca
Theo H Fenton, consultant paediatrician,Mayday
Hospital, Croydon
http://bmj.bmjjournals.com/cgi/qa-display/short/
bmj_el;49860
This exchange was posted on the Q&A section of bmj.com. If
you want to respond to the question, or ask a new question of
your own, follow the link above or go to
http://bmj.com/q&a
Number of subjects who were or were not exposed to secondhand smoke at home and odds ratios (adjusted for age and education, and for sex when men
and women were combined) for mortality in people aged 60 or over, Hong Kong. Values are odds ratio (95% confidence interval) unless indicated otherwise
Cause of death
By sex
All
By exposure (compared with no exposure)
Men Women
1 smoker 2 or more smokers
P for
trend
Exposed/not
exposed
Odds ratio
(95% CI)
Exposed/not
exposed
Odds ratio
(95% CI)
Cases
Cancer:
Lung cancer 33/112 1.34 (0.82 to 2.17) 96/83 1.38 (0.94 to 2.04) 1.39 (1.03 to 1.88)* 1.30 (0.94 to 1.80) 1.74 (1.06 to 2.86)* 0.014
All cancers 166/685 1.16 (0.85 to 1.60) 396/368 1.35 (1.03 to 1.76)* 1.27 (1.03 to 1.55)* 1.14 (0.92 to 1.43) 1.74 (1.22 to 2.48)*** 0.003
Respiratory:
COPD 27/69 1.67 (0.95 to 2.94) 27/15 2.90 (1.34 to 6.29)** 1.99 (1.28 to 3.10)*** 1.85 (1.14 to 3.00)* 2.51 (1.22 to 5.18)* 0.002
All respiratory 103/374 1.29 (0.87 to 1.92) 126/118 1.52 (1.01 to 2.27)* 1.41 (1.07 to 1.87)* 1.31 (0.97 to 1.78) 1.80 (1.11 to 2.91)* 0.007
Circulatory:
Stroke 65/232 1.31 (0.87 to 1.99) 158/142 1.57 (1.11 to 2.24)* 1.49 (1.15 to 1.94)*** 1.34 (1.01 to 1.79)* 2.08 (1.33 to 3.25)*** 0.001
IHD 74/285 1.30 (0.88 to 1.93) 113/112 1.39 (0.95 to 2.04) 1.35 (1.03 to 1.76)* 1.26 (0.94 to 1.69) 1.68 (1.05 to 2.68)* 0.015
All circulatory 177/664 1.29 (0.93 to 1.79) 342/334 1.36 (1.02 to 1.81)* 1.35 (1.09 to 1.68)** 1.27 (1.01 to 1.61)* 1.66 (1.13 to 2.42)** 0.002
Injury and poisoning 14/63 1.02 (0.53 to 1.97) 20/29 0.81 (0.43 to 1.52) 0.95 (0.60 to 1.49) 1.03 (0.64 to 1.67) 0.65 (0.25 to 1.74) 0.594
All causes 552/2128 1.25 (0.94 to 1.66) 1112/1046 1.41 (1.11 to 1.79)** 1.34 (1.12 to 1.61)*** 1.24 (1.02 to 1.52)* 1.73 (1.24 to 2.40)*** <0.001
Controls 71/347 150/195
COPD=chronic obstructive pulmonary disease; IHD=ischaemic heart disease.
*P<0.05, **P<0.01, ***P<0.005 on logistic regression.
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